Sickle Cell Disease Care Planning for School Nurses

Abstract

Schoolchildren with sickle cell disease (SCD) experience physiologic and psychologic stress that can affect school functioning, mental well-being, and physical health. Student needs are unique and individualized; however, school nurses can support students and families with SCD through comprehensive and thorough care planning efforts. In addition to components specific to individual prescriptions and other nonpharmacological therapies, school nurses should consider school access and inclusion, pain management, racism, and disease self-management when care planning. As a healthcare provider who may have several continuous years of near-daily contact with students, the school nurse is an imperative provider, educator, and advocate for students learning to manage their SCD and avoid the related complications and challenges.

Keywords

sickle cell anemia pain Framework for 21st Century School Nursing Practice health education student care plans care coordination

Get full access to this article

View all access options for this article.

References

American Academy of Family Physicians. (2019). Institutional racism in the health care system. https://www.aafp.org/about/policies/all/institutional-racism.html

Balsamo

Shabanova

Carbonella

Szondy

M. V.

Kalbfeld

Thomas

D.-A.

Santucci

Grossman

Pashankar

(2019). Improving care for sickle cell pain crisis using a multidisciplinary approach. Pediatrics, 143(5), e20182218. https://doi.org/10.1542/peds.2018-2218

Barton-Gooden

Grindley

Knight-Madden

Asnani

(2019). Gender influences on the health of adolescents with sickle cell disease. Psychology, Health & Medicine, 24(4), 470-480. https://doi.org/10.1080/13548506.2018.1533985

Blake

Asnani

Leger

R. R.

Harris

Odesina

Hemmings

D. L.

Morris

D. A.

Knight-Madden

Wagner

Asnani

M. R.

(2018). Stigma and illness uncertainty: Adding to the burden of sickle cell disease. Hematology, 23(2), 122-130. https://doi.org/10.1080/10245332.2017.1359898

Byar

(2021). Concepts of care for patients with hematologic problems. In Ignatavicius

D. D.

Workman

M. L.

Rebar

C. R.

Heimgartner

N. M.

(Eds.), Medical surgical nursing: Concepts for interprofessional collaborative care (10th ed., pp. 793-798). Elsevier.

Connolly

M. E.

Bills

S. E.

Hardy

S. J.

(2019). Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease. Pediatric Blood & Cancer, 66(9). https://doi.org/10.1002/pbc.27823

Devakumar

Selvarajah

Shannon

Muraya

Lasoye

Corona

Paradies

Abubakar

Achiume

E. T.

(2020). Racism, the public health crisis we can no longer ignore. Lancet, 395(10242), e112-e113. https://doi.org/10.1016/S0140-6736(20)31371-4

Diaz-Hennessy

O’Shea

K. K.

(2019). Virtual reality: Augmenting the acute pain experience in children. Pediatric Nursing, 45(3), 122-127.

Engel

E. R.

Howard

A. L.

Ankus

E. J.

Rico

J. F.

(2020). Advances in sickle cell disease management. Advances in Pediatrics, 67, 57–71. https://doi.org/10.1016/j.yapd.2020.03.001

10.

Farooq

Mogayzel

P. J.

Lanzkron

Haywood

Strouse

J. J.

(2020). Comparison of U.S. federal and foundation funding of research for sickle cell disease and cystic fibrosis and factors associated with research productivity. JAMA Network Open, 3(3), e201737. https://doi.org/10.1001/jamanetworkopen.2020.1737

11.

Graves

J. K.

Hodge

Jacob

(2016). Depression, anxiety, and quality of life in children and adolescents with sickle cell disease. Pediatric Nursing, 42(3), 113-119.

12.

Hall

W. J.

Chapman

M. V.

Lee

K. M.

Merino

Y. M.

Thomas

T. W.

Payne

B. K.

Eng

Day

S. H.

Coyne-Beasley

(2015). Implicit racial/ethnic bias among health care professionals and its influence on health care outcomes: A systematic review. American Journal of Public Health, 105(12), 2588. https://doi.org/10.2105/AJPH.2015.302903a

13.

Haridasa

DeBaun

M. R.

Sanger

Mayo-Gamble

T. L.

(2019). Student perspectives on managing sickle cell disease at school. Pediatric Blood & Cancer, 66(2), e27507. https://doi.org/10.1002/pbc.27507

14.

Heeney

M. M.

Ware

R. E.

(2010). Hydroxyurea for children with sickle cell disease. Hematology/Oncology Clinics of North America, 24(1), 199-214. https://doi.org/10.1016/j.hoc.2009.11.002

15.

Kuehn

B. M.

(2021). AHA takes aim at structural racism as a public health crisis. Circulation, 143(5), 501-502. https://doi.org/10.1161/CIRCULATIONAHA.120.053306

16.

Lance

E. I.

Comi

A. M.

Johnston

M. V.

Casella

J. F.

Shapiro

B. K.

(2015). Risk ractors for attention and behavioral issues in pediatric sickle cell disease. Clinical Pediatrics, 54(11), 1087-1093. https://doi.org/10.1177/0009922815594356

17.

Leonard

Tisdale

J. F.

(2018). Stem cell transplantation in sickle cell disease: Therapeutic potential and challenges faced. Expert Review of Hematology, 11(7), 547-565. https://doi.org/10.1080/17474086.2018.1486703

18.

Mahmood

L. A.

Reece-Stremtan

Idiokitas

Martin

Margulies

Hardy

S. J.

Bost

J. E.

Darbari

D. S.

(2020). Acupuncture for pain management in children with sickle cell disease. Complementary Therapies in Medicine, 49, 102287. https://doi.org/10.1016/j.ctim.2019.102287

19.

Matthie

Jenerette

McMillan

(2015). Role of self-care in sickle cell disease. Pain Management Nursing, 16(3), 257-266. https://doi.org/10.1016/j.pmn.2014.07.003

20.

Maughan

Bobo

Butler

Schantz

(2016). Framework for 21st Century School Nursing Practice. NASN School Nurse, 31(1), 45-53. https://doi.org/10.1177/1942602X15618644

21.

Moody

Abrahams

Baker

Santizo

Manwani

Carullo

Eugenio

Carroll

(2017). A randomized trial of yoga for children hospitalized with sickle cell vaso-occlusive crisis. Journal of Pain and Symptom Management, 53(6), 1026-1034. https://doi.org/10.1016/j.jpainsymman.2016.12.351

22.

Mougianis

Cohen

L. L.

Martin

Shneider

Bishop

(2020). Racism and health-related quality of life in pediatric sickle cell disease: Roles of depression and support. Journal of Pediatric Psychology, 45(8), 858-866. https://doi.org/10.1093/jpepsy/jsaa035

23.

Mulchan

S. S.

Valenzuela

J. M.

Crosby

L. E.

Diaz Pow Sang

(2016). Applicability of the SMART model of transition readiness for sickle-cell disease. Journal of Pediatric Psychology, 41(5), 543-554. https://doi.org/10.1093/jpepsy/jsv120

24.

National Association of School Nurses. (2020). Position brief: Eliminate racism to optimize student health and learning. https://www.nasn.org/advocacy/professional-practice-documents/positionbriefs/pb-racism

25.

Ogu

U. O.

Thomas

Chan

Sebastian

Minniti

C. P.

(2019). Barriers to the use of Endari^TM in an urban adult sickle cell center. Blood, 134(Suppl. 1), 2287. https://doi.org/10.1182/blood-2019-126666

26.

Power-Hays

McGann

P. T.

(2020). When actions speak louder than words: Racism and sickle cell disease. New England Journal of Medicine, 383(20), 1902-1903. https://doi.org/10.1056/NEJMp2022125

27.

Psihogios

A. M.

Daniel

L. C.

Tarazi

Smith-Whitley

Patterson

C. A.

Barakat

L. P.

(2018). Family functioning, medical self-management, and health outcomes among school-aged children with sickle cell disease: A mediation model. Journal of Pediatric Psychology, 43(4), 423-433. https://doi.org/10.1093/jpepsy/jsx120

28.

Rodgers-Melnick

S. N.

Matthie

Jenerette

Griest Pell

T. J.

Lane

Margevicius

Little

J. A.

(2018). The effects of a single electronic music improvisation session on the pain of adults with sickle cell disease: A mixed methods pilot study. Journal of Music Therapy, 55(2), 156-185. https://doi.org/10.1093/jmt/thy004

29.

Schuchard

S. B.

Lissick

J. R.

Nickel

Watson

Moquist

K. L.

Blaylark

R. M.

Nelson

S. C.

(2019). Hydroxyurea use in young infants with sickle cell disease. Pediatric Blood & Cancer, 66(7), e27650. https://doi.org/10.1002/pbc.27650

30.

Serjeant

G. R.

(2013). The natural history of sickle cell disease. Cold Spring Harbor Perspectives in Medicine, 3(10), a011783. https://doi.org/10.1101/cshperspect.a011783

31.

Sil

Lai

Lee

J. L.

Gilleland Marchak

Thompson

Cohen

Lane

Dampier

(2020). Preliminary evaluation of the clinical implementation of cognitive-behavioral therapy for chronic pain management in pediatric sickle cell disease. Complementary Therapies in Medicine, 49, 102348. https://doi.org/10.1016/j.ctim.2020.102348

32.

Simmons

L. A.

Williams

Silva

Keefe

Tanabe

(2019). Acceptability and feasibility of a mindfulness-based intervention for pain catastrophizing among persons with sickle cell disease. Pain Management Nursing, 20(3), 261-269. https://doi.org/10.1016/j.pmn.2018.10.002

33.

Smaldone

Findley

Manwani

Jia

Green

N. S.

(2018). HABIT, a randomized feasibility trial to increase hydroxyurea adherence, suggests improved health-related quality of life in touths with sickle cell disease. Journal of Pediatrics, 197, 177-185.e2. https://doi.org/10.1016/j.jpeds.2018.01.054

34.

Smith

Reinman

Schatz

Roberts

C. W.

(2018). Parent perspectives on pain management in preschool-age children with sickle cell disease. Journal of Pediatric Oncology Nursing, 35(1), 16-24. https://doi.org/10.1177/1043454217735829

35.

Solodiuk

J. C.

Jantz

Fuller

Osterling

Foxman

Grafft

Hanser

(2020). The use of music by adolescents and young adults with sickle cell disease. Creative Nursing, 26(3), 189-196. https://doi.org/10.1891/CRNR-D-19-00069

36.

Stanton

M. V.

Jonassaint

C. R.

Bartholomew

F. B.

Edwards

Richman

DeCastro

Williams

(2010). The association of optimism and perceived discrimination with health care utilization in adults with sickle cell disease. Journal of the National Medical Association, 102(11), 1056-1064. https://doi.org/10.1016/S0027-9684(15)30733-1

37.

U.S. Food and Drug Administration. (2017a). FDA approves hydroxyurea for treatment of pediatric patients with sickle cell anemia. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-hydroxyurea-treatment-pediatric-patients-sickle-cell-anemia

38.

U.S. Food and Drug Administration. (2017b). FDA approves new treatment for sickle cell disease. https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-sickle-cell-disease

39.

Vandiver

B. J.

(2020). Message from the editor-in-chief: Racism as public health crisis. Journal of Black Psychology, 46(5), 347-350. https://doi.org/10.1177/0095798420956806

40.

Ware

R. E.

McGann

P. T.

Quinn

C. T.

(2019). Hydroxyurea for children with sickle cell anemia: Prescribe it early and often. Pediatric Blood & Cancer, 66(8), e27778. https://doi.org/10.1002/pbc.27778

41.

Yearby

(2021). Race based medicine, colorblind disease: How racism in medicine harms us all. American Journal of Bioethics, 21(2), 19-27. https://doi.org/10.1080/15265161.2020.1851811